Lichao Qiao - Publications

Increase in serum prolactin levels as a potential biomarker in Crohn's disease: a prospective cohort study.

Journal: Frontiers in medicine

Published: November 02, 2025

Durable clinical and deep remission with ustekinumab in perianal fistulizing Crohn's disease: A 2-year retrospective real-world cohort study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: June 04, 2025

Editorial: Development and Validation of a Multimodal Machine Learning Model for Diagnosing and Assessing Risk of Crohn's Disease in Patients With Perianal Fistulae: Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: January 12, 2025

Development and Validation of a Multimodal Machine Learning Model for Diagnosing and Assessing Risk of Crohn's Disease in Patients With Perianal Fistula.

Journal: Alimentary pharmacology & therapeutics

Published: October 18, 2024

Targeting NCAPD2 as a Therapeutic Strategy for Crohn's Disease: Implications for Autophagy and Inflammation.

Journal: Inflammatory bowel diseases

Published: April 07, 2024

Monitoring-Based Model for Personalizing Fecal Incontinence in Patients With Crohn's Disease: A Multicenter Inception Cohort Study.

Journal: Inflammatory bowel diseases

Published: September 11, 2023

Adjuvant chemoradiotherapy does not improve outcomes in patients with fistula-associated anal adenocarcinoma undergoing abdominoperineal resection.

Journal: Frontiers in oncology

Published: October 04, 2022

Primary malignant tumours and malignant transformation of cysts in the retrorectal space: MRI diagnosis and treatment outcomes.

Journal: Gastroenterology report

Published: January 23, 2022

Total Flavone of Abelmoschus manihot Ameliorates TNBS-Induced Colonic Fibrosis by Regulating Th17/Treg Balance and Reducing Extracellular Matrix.

Journal: Frontiers in pharmacology

Published: September 17, 2021

Thalidomide Prevented and Ameliorated Pathogenesis of Crohn's Disease in Mice via Regulation of Inflammatory Response and Fibrosis.

Journal: Frontiers in pharmacology

Published: July 16, 2019